191 related articles for article (PubMed ID: 35169199)
21. Skp2 regulates androgen receptor through ubiquitin-mediated degradation independent of Akt/mTOR pathways in prostate cancer.
Li B; Lu W; Yang Q; Yu X; Matusik RJ; Chen Z
Prostate; 2014 Apr; 74(4):421-32. PubMed ID: 24347472
[TBL] [Abstract][Full Text] [Related]
22. FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2.
Zuo T; Liu R; Zhang H; Chang X; Liu Y; Wang L; Zheng P; Liu Y
J Clin Invest; 2007 Dec; 117(12):3765-73. PubMed ID: 18008005
[TBL] [Abstract][Full Text] [Related]
23. Ubiquitination of p27Kip1 requires physical interaction with cyclin E and probable phosphate recognition by SKP2.
Ungermannova D; Gao Y; Liu X
J Biol Chem; 2005 Aug; 280(34):30301-9. PubMed ID: 15980415
[TBL] [Abstract][Full Text] [Related]
24. SKP2 promotes breast cancer tumorigenesis and radiation tolerance through PDCD4 ubiquitination.
Li C; Du L; Ren Y; Liu X; Jiao Q; Cui D; Wen M; Wang C; Wei G; Wang Y; Ji A; Wang Q
J Exp Clin Cancer Res; 2019 Feb; 38(1):76. PubMed ID: 30760284
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of S-phase kinase-associated protein-2 expression in MCF-7 inhibits cell growth and enhances the cytotoxic effects of epirubicin.
Sun L; Cai L; Yu Y; Meng Q; Cheng X; Zhao Y; Sui G; Zhang F
Acta Biochim Biophys Sin (Shanghai); 2007 Dec; 39(12):999-1007. PubMed ID: 18064393
[TBL] [Abstract][Full Text] [Related]
26. The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer.
Bochis OV; Irimie A; Pichler M; Berindan-Neagoe I
J Gastrointestin Liver Dis; 2015 Jun; 24(2):225-34. PubMed ID: 26114183
[TBL] [Abstract][Full Text] [Related]
27. USP19 deubiquitinating enzyme supports cell proliferation by stabilizing KPC1, a ubiquitin ligase for p27Kip1.
Lu Y; Adegoke OA; Nepveu A; Nakayama KI; Bedard N; Cheng D; Peng J; Wing SS
Mol Cell Biol; 2009 Jan; 29(2):547-58. PubMed ID: 19015242
[TBL] [Abstract][Full Text] [Related]
28. Targeting the oncogenic E3 ligase Skp2 in prostate and breast cancer cells with a novel energy restriction-mimetic agent.
Wei S; Chu PC; Chuang HC; Hung WC; Kulp SK; Chen CS
PLoS One; 2012; 7(10):e47298. PubMed ID: 23071779
[TBL] [Abstract][Full Text] [Related]
29. Deubiquitinase ubiquitin-specific protease 9X regulates the stability and function of E3 ubiquitin ligase ring finger protein 115 in breast cancer cells.
Lu Q; Lu D; Shao ZM; Li DQ
Cancer Sci; 2019 Apr; 110(4):1268-1278. PubMed ID: 30689267
[TBL] [Abstract][Full Text] [Related]
30. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.
Bashir T; Dorrello NV; Amador V; Guardavaccaro D; Pagano M
Nature; 2004 Mar; 428(6979):190-3. PubMed ID: 15014502
[TBL] [Abstract][Full Text] [Related]
31. The expression and prognosis of Emi1 and Skp2 in breast carcinoma: associated with PI3K/Akt pathway and cell proliferation.
Liu X; Wang H; Ma J; Xu J; Sheng C; Yang S; Sun L; Ni Q
Med Oncol; 2013 Dec; 30(4):735. PubMed ID: 24277465
[TBL] [Abstract][Full Text] [Related]
32. E3 ubiquitin ligase Wwp1 regulates ciliary dynamics of the Hedgehog receptor Smoothened.
Lv B; Stuck MW; Desai PB; Cabrera OA; Pazour GJ
J Cell Biol; 2021 Sep; 220(9):. PubMed ID: 34161574
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus X protein enhances Myc stability by inhibiting SCF(Skp2) ubiquitin E3 ligase-mediated Myc ubiquitination and contributes to oncogenesis.
Lee S; Kim W; Ko C; Ryu WS
Oncogene; 2016 Apr; 35(14):1857-67. PubMed ID: 26165841
[TBL] [Abstract][Full Text] [Related]
34. Substrate recognition and ubiquitination of SCFSkp2/Cks1 ubiquitin-protein isopeptide ligase.
Xu S; Abbasian M; Patel P; Jensen-Pergakes K; Lombardo CR; Cathers BE; Xie W; Mercurio F; Pagano M; Giegel D; Cox S
J Biol Chem; 2007 May; 282(21):15462-70. PubMed ID: 17409098
[TBL] [Abstract][Full Text] [Related]
35. E3 ubiquitin ligase Skp2 as an attractive target in cancer therapy.
Hao Z; Huang S
Front Biosci (Landmark Ed); 2015 Jan; 20(3):474-90. PubMed ID: 25553462
[TBL] [Abstract][Full Text] [Related]
36. Relationship between levels of Skp2 and P27 in breast carcinomas and possible role of Skp2 as targeted therapy.
Zheng WQ; Zheng JM; Ma R; Meng FF; Ni CR
Steroids; 2005 Oct; 70(11):770-4. PubMed ID: 16024059
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer.
Chiappetta G; De Marco C; Quintiero A; Califano D; Gherardi S; Malanga D; Scrima M; Montero-Conde C; Cito L; Monaco M; Motti ML; Pasquinelli R; Agosti V; Robledo M; Fusco A; Viglietto G
Endocr Relat Cancer; 2007 Jun; 14(2):405-20. PubMed ID: 17639054
[TBL] [Abstract][Full Text] [Related]
38. Regulation of Skp2 levels by the Pim-1 protein kinase.
Cen B; Mahajan S; Zemskova M; Beharry Z; Lin YW; Cramer SD; Lilly MB; Kraft AS
J Biol Chem; 2010 Sep; 285(38):29128-37. PubMed ID: 20663873
[TBL] [Abstract][Full Text] [Related]
39. E3-ligase Skp2 predicts poor prognosis and maintains cancer stem cell pool in nasopharyngeal carcinoma.
Wang J; Huang Y; Guan Z; Zhang JL; Su HK; Zhang W; Yue CF; Yan M; Guan S; Liu QQ
Oncotarget; 2014 Jul; 5(14):5591-601. PubMed ID: 25015320
[TBL] [Abstract][Full Text] [Related]
40. CD28 costimulation mediates transcription of SKP2 and CKS1, the substrate recognition components of SCFSkp2 ubiquitin ligase that leads p27kip1 to degradation.
Appleman LJ; Chernova I; Li L; Boussiotis VA
Cell Cycle; 2006 Sep; 5(18):2123-9. PubMed ID: 16969077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
